For some individuals, intermittent fasting may contribute to disordered eating behaviors, including food obsession, bingeing, or purging
and screen for affective disorders which can influence healthfulness of dietary choices and changes in calorie intake [121]
On the FDAs Adverse Events Reporting System, a public dashboard, there are hundreds of reports from 2024 of eye disorders tied to Ozempic, though the FDA warns the dashboard data may contain duplicates and the data has not been independently verified
As a result, many patients experience: Reduced appetite Improved satiety Better metabolic regulation Gradual, sustainable weight loss Semaglutide and tirzepatide are two of the most widely discussed medications in this category
The surrounding text makes a defensible point that hunger becomes an unreliable proxy for energy need, but converting that into a blanket instruction is not the same thing
Some Wegovy patients have developed gallbladder disease (sometimes requiring gallbladder removal)